CD146hiCD73hi Mesenchyme Supports Ex Vivo Maintenance of Clonogenic, Engraftable, and Self-Renewing HSPCs
CD146hiCD73hi and CD146loCD73lo mesenchymal cells generated from H1-derived hEMP were isolated and co-cultured as monolayers with CB CD34+ cells in 5% serum without added cytokines. After 2 weeks, hematopoietic cells were assayed (A–G) in vitro and (H–J) in vivo.
(A) Total number of live (DAPI–) CD45+ cells recovered from co-cultures, shown as cell yield normalized to 1,000 input CD34+ cells.
(B) Representative FACS analysis of CD45+ gated cells from co-cultures.
(C–G) Cell yield of CD34+, CD34+ Lin−, CD14+ myeloid, CD10+/CD19+ B lymphoid cells, and CFU (after re-plating) recovered from 2-week CD146hiCD73hi co-cultures, normalized to CD146loCD73lo co-cultures.
(A and C–G) n = 16 independent experiments, each in duplicate. Shown are mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001; unpaired two-tailed Student's t test.
(H) Flow cytometry showing gating for the detection of human cells (hCD45+HLA ABC+) and multi-lineage reconstitution after primary transplant. PBS control with no cells injected.
(I) Proportion of mice with engraftment, i.e., detection of >1% human cells after primary transplant (1°) with 1 × 105 CD45+ cells obtained either from fresh CB CD34+ cells (CB w/o culture), or 2 weeks after co-culture on CD146hiCD73hi or CD146loCD73lo.
(J) Engraftment (percent of human cells) of mice 6 weeks after primary and secondary transplants (n = 5 independent experiments, total 9–14 mice per group; ∗∗∗p <.0001; ns, not significant).
Error bars represent SEM. See also Figure S3.